You are here Home Guidance and resources Resources International scientific guidelines adopted in Australia International scientific guideline: Note for guidance on antiarrhythmics CPMP/EWP/237/95 adopted by the Therapeutic Goods Administration (TGA) Listen Print Share LinkedIn (Twitter) Facebook Email Loading... About this guideline Overseas effective date: 1 August 1997 Categories: Clinical efficacy and safety | Cardiovascular system | Arrythmias Access this international scientific guideline TGA annotations Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter [CPMP/EWP/237/95] For more information see International scientific guidelines adopted in Australia. Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.